>
Abbott India logo

ABBOTINDIA - Abbott India Share Price

₹14959.9 -89.8  -0.6%

Last Trade - 13/04/21

Sector
Healthcare
Size
Large Cap
Market Cap ÂŁ3.09bn
Enterprise Value ÂŁ2.91bn
Revenue ÂŁ405.3m
Position in Universe 124th / 3106
Bullish
Bearish
Unlock ABBOTINDIA Revenue
Momentum
Relative Strength (%)
1m +6.75%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -19.2%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
22,886 26,456 29,387 33,071 36,786 40,931 43,418 48,750 +12.3%
+19.6 +12.1 +8.4 +34.5 +19.3 +33.6 +17.7 +13.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, AbbottIndia Limited revenues increased 3% to RS32.14B. Net incomeincreased 12% to RS5.38B. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income benefited fromOther expenses decrease of 13% to RS3.42B (expense),Depreciation and amortisation expense decrease of 4% toRS430.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ABBOTINDIA
Graphical History

Revenue

ABBOTINDIA Revenue Unlock ABBOTINDIA Revenue

Net Income

ABBOTINDIA Net Income Unlock ABBOTINDIA Revenue

Normalised EPS

ABBOTINDIA Normalised EPS Unlock ABBOTINDIA Revenue

PE Ratio Range

ABBOTINDIA PE Ratio Range Unlock ABBOTINDIA Revenue

Dividend Yield Range

ABBOTINDIA Dividend Yield Range Unlock ABBOTINDIA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
ABBOTINDIA EPS Forecasts Unlock ABBOTINDIA Revenue
Profile Summary

Abbott India Limited is a healthcare company engaged in pharmaceuticals business. The Company has a portfolio of science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals. Its business operations are divided into four business divisions: Women's Health & Gastrointestine, Gastroenterology and Hepatic Care; Specialty Care; GenNext & Vaccines, and Consumer Care. Women's Health & Gastrointestine, Gastroenterology and Hepatic Care division has a mix of global and local brands present in the pregnancy, constipation and liver diseases segments. The Specialty Care division consists of a range of products in the treatment of central nervous system and metabolic disorders. The GenNext division focuses on several therapy areas, including pain management, vitamins and pregnancy. Its vaccines include Enteroshield (typhoid vaccine) and Rotasure (rotavirus diarrhea vaccine). The Consumer Care division is present in the over the counter antacid segment.

Directors
Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated August 22, 1944
Public Since November 3, 1994
No. of Shareholders: 51,442
No. of Employees: 3,551
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange National Stock Exchange of India
Shares in Issue 21,250,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
ABBOTINDIA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for ABBOTINDIA
Upcoming Events for ABBOTINDIA
Frequently Asked Questions for Abbott India
What is the Abbott India share price?

As of 13/04/21, shares in Abbott India are trading at ₹14959.9, giving the company a market capitalisation of ÂŁ3.09bn. This share price information is delayed by 15 minutes.

How has the Abbott India share price performed this year?

Shares in Abbott India are currently trading at ₹14959.9 and the price has moved by -12.45% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Abbott India price has moved by -44.94% over the past year.

What are the analyst and broker recommendations for Abbott India?

Of the analysts with advisory recommendations for Abbott India, there are there are currently 5 "buy" , 1 "hold" and 2 "sell" recommendations. The overall consensus recommendation for Abbott India is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Abbott India next release its financial results?

Abbott India is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Abbott India dividend yield?

The Abbott India dividend yield is 0.72% based on the trailing twelve month period.

Does Abbott India pay a dividend?

Last year, Abbott India paid a total dividend of 0.107k, and it currently has a trailing dividend yield of 0.72%. Looking ahead, Abbott India has not announced an ex-dividend date yet.

When does Abbott India next pay dividends?

Abbott India has yet to annouce their ex-dividend date. The historic dividend yield on Abbott India shares is currently 0.72%.

How do I buy Abbott India shares?

To buy shares in Abbott India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Abbott India?

Shares in Abbott India are currently trading at ₹14959.9, giving the company a market capitalisation of ÂŁ3.09bn.

Where are Abbott India shares listed? Where are Abbott India shares listed?

Here are the trading details for Abbott India:

Country of listing: India
Exchange: NSI
Ticker Symbol: ABBOTINDIA
What kind of share is Abbott India?

Based on an overall assessment of its quality, value and momentum, Abbott India is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Abbott India share price forecast 2021?

Shares in Abbott India are currently priced at ₹14959.9. At that level they are trading at 19.82% discount to the analyst consensus target price of 0.00.

Analysts covering Abbott India currently have a consensus Earnings Per Share (EPS) forecast of 328.637 for the next financial year.

How can I tell whether the Abbott India share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abbott India. Over the past six months, the relative strength of its shares against the market has been -24.11%. At the current price of ₹14959.9, shares in Abbott India are trading at -3.4% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Abbott India PE Ratio?

The Abbott India PE ratio based on its reported earnings over the past 12 months is 48.97. The shares are currently trading at ₹14959.9.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Abbott India?

Abbott India's management team is headed by:

Munir Ahmed Shaikh - NEC
Sudarshan Jain - IND
Kaiyomarz Marfatia - NED
Rajiv Sonalker - CFO
Krupa Anandpara - CCO
Rashmi Hegde - OTH
Sandeep Khandelwal - OTH
Rumy Kanga - OTH
Purnajit Gupta - DHR
Vishwanath Swarup - DSL
Mahadeo Karnik - OTH
Ambati Venu - VPR
Shalini Kamath - IND
Anil Joseph - MDR
Karen Peterson - NED
Who are the major shareholders of Abbott India?

Here are the top five shareholders of Abbott India based on the size of their shareholding:

Abbott Laboratories Corporation
Percentage owned: 74.99% (15.9m shares)
Goldman Sachs Asset Management International Investment Advisor
Percentage owned: 0.78% (166k shares)
L&T Investment Management Limited Investment Advisor/Hedge Fund
Percentage owned: 0.71% (150k shares)
Canara Robeco Asset Management Company Ltd. Investment Advisor
Percentage owned: 0.49% (104k shares)
SBI Funds Management Pvt. Ltd. Investment Advisor
Percentage owned: 0.46% (97.3k shares)
Similar to ABBOTINDIA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.